Increased sectioning of pathologic specimens with ductal carcinoma in situ of the breast: Are there clinical consequences?

Clinical Breast Cancer

Volumn 4, Issue 3, 2003, Pages 198-202

  Miller, Keith L ^a   Marks, Lawrence B ^a   Barrier Jr , Robert C ^a   Leight, George S ^a   Clough, Robert W ^a   Prosnitz, Robert G ^a   Bentley, Rex C ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Excisional biopsy; Margins; Specimen processing

Indexed keywords

ADULT; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER GRADING; CANCER STAGING; CARCINOMA IN SITU; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; ONCOLOGY; PAGET NIPPLE DISEASE; RETROSPECTIVE STUDY;

EID: 0141614009     PISSN: 15268209     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1526-8209(11)70626-7     Document Type: Article

References (15)

1. Winer EP, Morrow M, Osborne CK, et al. Malignant tumors of the breast. In: Devita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. Philadelphia: Lipincott Williams & Wilkins, 2001:1651-1717.
2. Jemal A, Murray T, Samuels A, et al. Cancer statistics, 2003. CA Cancer J Clin 2003; 52:5-26.
3. Ernster VL, Barclay J, Kerlikowske K, et al. Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 1996; 275:913-918.
4. Pathological examination and reporting of breast specimens. In: Trott PA, Lakhani SR, Sloane JP. Biopsy Pathology of the Breast (Biopsy Pathology Series, 24). 2nd edition. London: Edward Arnold, 2001:10-27.
5. Fisher ER, Dignam J, Tan-Chiu E, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of protocol B-17: intraductal carcinoma. Cancer 1999; 86:429-438.
6. Silverstein MJ, Lagios MD, Groshen S, et al. The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med 1999; 340:1455-1461.
7. Solin LJ, Fourquet A, Vicini FA, et al. Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation: long-term outcome and prognostic significance of patient age and margin status. Int J Radiat Oncol Biol Phys 2001; 50:991-1002.
8. Bijker N, Peterse JL, Duchateau L, et al. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer trial 10853. J Clin Oncol 2001; 19:2263-2271.
9. Morrow M, Schnitt SJ. Treatment selection in ductal carcinoma in situ. JAMA 2000; 283:453-455.
10. Schnitt SJ, Connolly JL. Processing and evaluation of breast excision specimens: A clinically oriented approach. Am J Clin Pathol 1992; 98:125-137.
11. Owings DV, Hann L, Schnitt SJ. How thoroughly should needle localization breast biopsies be sampled for microscopic examination? A prospective mammographic/pathologic correlative study. Am J Surg Pathol 1990; 14:578-583.
12. Fitzgibbons PL, Connolly JL, Page DL. Breast. In: Compton CC, Henson DE, Hammond EH, et al, eds. Reporting on Cancer Specimens. Chicago: American College of Pathologists, 2000:1-18.
13. Nakhleh RE, Jones B, Zarbo RJ. Mammographically directed breast biopsies. A college of American Pathologists Q-probe study of clinical physician expectations and of specimen handling and reporting characteristics in 434 institutions. Arch Pathol Lab Med 1997; 121:11-18
14. Morrow M, Venta L, Stinson T, et al. Prospective comparison of stereotactic biopsy and surgical excision as diagnostic procedures for breast cancer patients. Ann Surg 2001; 233:537-541.
15. White RR, Halperin TJ, Olson JA Jr, et al. Impact of core needle breast biopsy on the surgical management of mammographic abnormalities. Ann Surg 2001; 233:769-777.